Founded in 2014 by orthopedic surgeon Dr. Steven Goldberg, Catalyst OrthoScience develops shoulder arthroplasty solutions that emphasize bone preservation, soft-tissue protection, and reproducible results. Its flagship total-shoulder systems and the recently launched Catalyst Fracture Shoulder System aim to deliver a more natural-feeling joint while streamlining surgical workflow for physicians. The company’s technology portfolio includes a growing list of issued and pending patents, and its products are already available to surgeons across the United States. Catalyst’s mission is to simplify complex procedures without compromising clinical outcomes, a strategy that has driven expanding surgeon adoption and enthusiasm. Backed by a strong investor base and a leadership team with a record of disciplined growth, the firm plans to accelerate commercial and clinical programs and broaden its footprint in hospital and ambulatory surgery center markets. The new $15 million growth financing strengthens the balance sheet and provides capital for continued innovation and market expansion.

Total raised

$60M

Funding rounds

6

Latest round

Equity

Latest activity

Oct 2025